/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Benchling, which makes cloud-based software to manage biotech R&D, raises a $100M Series F at a $6.1B valuation; Benchling was last valued at $4B in April

Bloomberg Michelle F Davis

Discussion

  • @benchling @benchling on x
    We announced our Series F, which we'll use to keep powering #biotech R&D. Check out @business to see how our customers are tackling humanity's most pressing challenges as they develop new medicines, crops & other breakthrough products faster than ever.👨🏾‍🔬 👩🏼‍🔬 https://www.bloomb…
  • @agoulburn Adam Goulburn on x
    Biology + drug discovery is scaling & automating at an accelerated rate never seen before @benchling is the software infrastructure layer leading that digitization. Kudos to Saji & his world class team! 🚀🚀🚀 @BrandonReeves08 👊 https://www.bloomberg.com/... https://twitter.com/...
  • @svangel SV Angel on x
    We are thrilled for @sajithw and team @benchling on their Series F announcement as they continue to help scientists solve today's global challenges. They're also hiring! https://benchling.com/... https://twitter.com/...
  • @menloventures @menloventures on x
    We congratulate @sajithw and the team at @Benchling on this milestone funding. We've long supported their mission to accelerate the process to bring new biologic products to market, with automation, software, and ML. https://www.bloomberg.com/...
  • @deenashakir Deena Shakir on x
    Congratulations to @Lux_Capital portfolio company @benchling on this next chapter to continue to power biotech innovation through software! Having the chance to learn from afar from Founder/CEO @sajithw has been an incredible privilege. https://twitter.com/...
  • @zachtratar Zach Tratar on x
    Biotechnology, such as mRNA vaccines & CRISPR, is still incredibly early — it will come to define the next couple decades, just like the internet defined the last ~20 years. Benchling is the R&D operating system accelerating this bend in history. I could see it hitting $100B+. ht…
  • @brandonreeves08 Brandon Reeves on x
    Congrats to @benchling team! At a $6.1B Series F what people may not realize is Benchling is still early in its chapters and will increasingly become one of the most important software platforms powering one of our most important industries (pharma/biotech) cc:@sajithw @daashu ht…
  • @malayhgandhi Malay Gandhi on x
    I'm hiring for corporate strategy, market strategy, corporate development, and business development (product/technical partnerships). Reach out if you're passionate about the century of biology! https://twitter.com/...
  • @willreed_21 Will Reed on x
    Biotech is transforming the world and scientists need R&D software designed for the new speed of science. All of us @sparkcapital are proud to continue to support @Benchling and their mission to help breakthrough products get to market faster. https://www.bloomberg.com/...
  • @zavaindar Zavain Dar on x
    Every layer of the discovery and development stack will be redesigned with automation, software, machine learning, and of course, cutting edge molecular biology and biochemistry. @Lux_Capital backed @Benchling led by @sajithw showing the way: https://www.bloomberg.com/... https:/…